XOMA Corporation (XOMA)

$20.57

-0.28 (-1.34%)
Rating:
Recommendation:
Buy
Symbol XOMA
Price $20.57
Beta 0.928
Volume Avg. 0.03M
Market Cap 235.543M
Shares () -
52 Week Range 15.68-32.09
1y Target Est -
DCF Unlevered XOMA DCF ->
DCF Levered XOMA LDCF ->
ROE 20.15% Buy
ROA 18.86% Buy
Operating Margin -
Debt / Equity 12.13% Neutral
P/E 24.49 Strong Buy
P/B 1.81 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest XOMA news


Mr. James Neal
Healthcare
Biotechnology
NASDAQ Global Market

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.